MENU
ARMP
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Armata Pharmaceuticals (ARMP) Earnings Date & Reports
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
ARMP is expected to report earnings to -41 cents per share on March 18
Q4'26
Est.
$-0.42
Q3'26
Beat
by $0.15
Q2'26
Beat
by $0.17
Q4'25
Missed
by $3.23
Q3'25
Missed
by $0.24
The last earnings report on November 11 showed earnings per share of -41 cents, beating the estimate of -56 cents. With 105.07K shares outstanding, the current market capitalization sits at 130.51M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Related Blogs
Interesting Articles
A.I. Advisor
published General Information
General Information
a developer of novel bacteriophage-based therapeutics
Industry Biotechnology
Industry
Biotechnology
Address
5005 McConnell Avenue
Phone
+1 310 665-2928
Employees
61
Web
https://www.armatapharma.com